Tim Somers

Mr. Tim Somers

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2024 in European Heart Journal - Imaging Methods and Practice
Verified
Journal Article
Open access
PDF file
MWMarleen van Wely
Marleen van Wely
MRMaxim J.P. Rooijakkers
Maxim J.P. Rooijakkers
NSNiels Stens
Niels Stens
SMSaloua El Messaoudi
Saloua El Messaoudi
TSTim Somers
Tim Somers
NRNiels Van Royen
Niels Van Royen
Transcatheter aortic valve replacement (TAVR) is the standard of care in aortic stenosis with results comparable to surgical aortic valve replacement. However, paravalvular regurgitation (PVR) is more common after TAVR. With the alteration of devices and implantation techniques, the incidence of moderate or more PVR has declined. Mild PVR is still common in around 30% of TAVR patients in low-risk trials. Progression of AS causes myocardial hypertrophy and varying degrees of diastolic dysfunction which may cause heart failure even in combination with small volumes of PVR. Any degree of PVR is associated with an increased risk of overall and cardiovascular mortality. Predictors of PVR are annular eccentricity, severe calcification of the aortic valve, bicuspid aortic valves, and type of prosthesis where balloon-expandable devices are associated with less PVR. PVR is diagnosed using echocardiography, aortic angiogram with or without videodensitometry, haemodynamic parameters, or cardiac magnetic resonance. PVR can be treated using post-dilation, interventional treatment using a vascular plug, or implantation of a second device. Successful post-dilation depends on balloon size which should at least be equal to or >95% of the mean annulus diameter. Implantation of a second device to reduce PVR is successful in ∼90% of cases, either through lengthening of the sealing skirt in case of inadequate position or through further expansion of the index device. Implantation of a vascular plug can successfully reduce PVR and reduce mortality.

Verified
Journal Article
Open access
PDF file
TSTim Somers
Tim Somers
SSSailay Siddiqi
Sailay Siddiqi
WMWim J. Morshuis
Wim J. Morshuis
FRFrans G.M. Russel
Frans G.M. Russel
TSTom J. J. Schirris
Tom J. J. Schirris
Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, and are the cornerstone of lipid-lowering treatment. They significantly reduce cardiovascular morbidity and mortality. However, musculoskeletal symptoms are observed in 7 to 29 percent of all users. The mechanism underlying these complaints has become increasingly clear, but less is known about the effect on cardiac muscle function. Here we discuss both adverse and beneficial effects of statins on the heart. Statins exert pleiotropic protective effects in the diseased heart that are independent of their cholesterol-lowering activity, including reduction in hypertrophy, fibrosis and infarct size. Adverse effects of statins seem to be associated with altered cardiomyocyte metabolism. In this review we explore the differences in the mechanism of action and potential side effects of statins in cardiac and skeletal muscle and how they present clinically. These insights may contribute to a more personalized treatment strategy.

1 January 2025 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
TSTim Somers
Tim Somers
SISandy Iskander
Sandy Iskander
AVAd F.T.M. Verhagen
Ad F.T.M. Verhagen
WLWilson W.L. Li
Wilson W.L. Li
Diaphragm elevation is commonly seen after cardiac surgery, mostly due to phrenic nerve injury. However, only historical data is available on the incidence of diaphragm elevation and its consequences during recovery. We aim to provide contemporary insights into the incidence of diaphragm dysfunction in patients undergoing cardiac surgery and its effect on postoperative outcomes. Records of all patients undergoing cardiac surgery through sternotomy between 2015 and 2016 at the Radboud University MedicalCentre were retrospectively reviewed. Diaphragm position and elevation were evaluated on available chest radiography. Right-sided diaphragm elevation was defined as the right diaphragm being > 3.0 cm above the left diaphragm; left-sided diaphragm elevation was defined as < 0.5 cm below or above the level of the right diaphragm. A total of 1510 patients have undergone cardiac surgery through sternotomy during the study period, of which 1316 patients were included in the final analysis. Of these 1316 patients, 13% (n = 179) had pre-existing diaphragm elevation, 27% (n = 351) had a new diaphragm elevation postoperative-y, and 60% (n = 786) had no diaphragm elevation. No statistically significant differences were found between the groups in the occurrence of postoperative (pulmonary) complications or mortality. Of patients who developed new diaphragm elevation postoperatively, 65% recovered in the follow-up period. New postoperative diaphragm elevation occurs in 27% of patients undergoing cardiac surgery. However, new postoperative diaphragm elevation is not associated with a higher incidence of postoperative complications and spontaneous recovery is seen in most patients.

16 February 2022 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
TSTim Somers
Tim Somers
HNHedwig M J M Nies
Hedwig M J M Nies
RKRoland R J van Kimmenade
Roland R J van Kimmenade
DBDennis G H Bosboom
Dennis G H Bosboom
GGGuillaume Geuzebroek
Guillaume Geuzebroek
WMWim J Morshuis
Wim J Morshuis
Background: Coarctation of the aorta accounts for 5–7% of congenital defects of the heart and great vessels. It requires treatment in the form of open surgical or percutaneous repair. Common long-term complications include re-stenosis and aneurysm formation. The formation of a false aneurysm is a complication with a significant morbidity and mortality.Case summary: We reviewed six cases of late false aneurysm after repair of a coarctation of the aorta. Our six cases developed a false aneurysm after an open surgical repair of a coarctation more than 30 years after initial surgical repair. All aneurysms were located at the aortic repair site.Discussion: The symptoms or risk factors in the described cases are not uniform and are difficult to include in a general follow-up protocol. Guidelines recommend frequent evaluation, but do not specify duration or intervals of imaging follow-up. Our cases support the necessity of life-long follow-up in patients with open aortic repairs irrespective of symptomatology.

24 September 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
TSTim Somers
Tim Somers
SSSailay Siddiqi
Sailay Siddiqi
MJMargit C.M. Janssen
Margit C.M. Janssen
WMWim J. Morshuis
Wim J. Morshuis
RMRenee G.C. Maas
Renee G.C. Maas
FRFrans G.M. Russel
Frans G.M. Russel
The success of statin therapy in reducing cardiovascular morbidity and mortality is contrasted by the skeletal muscle complaints, which often leads to nonadherence. Previous studies have shown that inhibition of mitochondrial function plays a key role in statin intolerance. Recently, it was found that statins may also influence energy metabolism in cardiomyocytes. This study assessed the effects of statin use on cardiac muscle ex vivo from patients using atorvastatin, rosuvastatin, simvastatin or pravastatin and controls. Cardiac tissue and skeletal muscle tissue were harvested during open heart surgery after patients provided written informed consent. Patients included were undergoing cardiac surgery and either taking statins (atorvastatin, rosuvastatin, simvastatin or pravastatin) or without statin therapy (controls). Contractile behaviour of cardiac auricles was tested in an ex vivo set-up and cellular respiration of both cardiac and skeletal muscle tissue samples was measured using an Oxygraph-2k. Finally, statin acid and lactone concentrations were quantified in cardiac and skeletal homogenates by LC-MS/MS. Fatty acid oxidation and mitochondrial complex I and II activity were reduced in cardiac muscle, while contractile function remained unaffected. Inhibition of mitochondrial complex III by statins, as previously described, was confirmed in skeletal muscle when compared to control samples, but not observed in cardiac tissue. Statin concentrations determined in skeletal muscle tissue and cardiac muscle tissue were comparable. Statins reduce skeletal and cardiac muscle cell respiration without significantly affecting cardiac contractility.

17 December 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
YHYannick J.J.M. Hazen
Yannick J.J.M. Hazen
PNPeter G. Noordzij
Peter G. Noordzij
GGGuillaume Geuzebroek
Guillaume Geuzebroek
JKJeroen Koets
Jeroen Koets
TSTim Somers
Tim Somers
TRThijs Rettig
Thijs Rettig